EDGAR Filing Documents for 0001628280-23-012596

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001628280-23-012596

Filing Date

2023-04-24

Accepted

2023-04-24 17:16:46

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	defa14a-2023.htm	DEFA14A	14985
2		vndadefa14a2023page1.jpg	GRAPHIC	491245
3		vndadefa14a2023page2.jpg	GRAPHIC	96485
	Complete submission text file	0001628280-23-012596.txt		819620

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037

Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400

Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)